Log In
BCIQ
Print this Print this
 

GMI-1051

  Manage Alerts
Collapse Summary General Information
Company GlycoMimetics Inc.
DescriptionLectin (PA-IL and PA-llL) antagonist
Molecular Target Lectins
Mechanism of ActionLectin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPseudomonas
Indication DetailsTreat and prevent infections caused by Pseudomonas aeruginosa
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today